ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Emcure Pharmaceuticals held its 45th Annual General Meeting on September 21, 2026. The meeting transacted ordinary and special business, including the approval of a final dividend.
Emcure Pharmaceuticals has issued a notice for its 45th Annual General Meeting to be held on September 21, 2026. The meeting will address financial statements, dividends, and directorship appointments.
Emcure Pharmaceuticals will hold its 45th AGM on September 21, 2026. The company fixed September 04, 2026, as the record date for a Rs. 3.60 per share dividend.
Emcure Pharmaceuticals Limited announced that its members approved the appointment of Mr. C S Muralidharan as an Independent Director via Postal Ballot. The appointment is for a three-year term effective April 01, 2026. The remote e-voting process concluded on April 24, 2026, with results announced today.
Emcure Pharmaceuticals Limited announced the successful passage of a special resolution via postal ballot on April 24, 2026. Shareholders approved the appointment of Mr. C S Muralidharan as an Independent Director for a three-year term effective April 01, 2026. The voting process was conducted electronically and confirmed as fair by the scrutinizer.
Emcure Pharmaceuticals Limited announced the successful passage of a special resolution via postal ballot to appoint Mr. C S Muralidharan as an Independent Director. The resolution was passed with a 99.9999% majority effective April 24, 2026. The filing includes the formal voting results and Scrutinizer's Report.